Ip-driven development
Drive innovation through proprietary intellectual property, fostering R&D and product development to establish a strong technological advantage.
Why invest in Arviva Therapeutics?
We unite science, technology, and talent to stay at the forefront of disease research. Focusing on innovation, performance, and trust, we aim to deliver sustainable value for our shareholders while creating an environment where employees can thrive.
Investor Area
Business operation model
Licensing-out, joint development and acquisitions
Innovate to expand our pipeline
Mergers and acquisitions
Acquire and merge drug pipelines to quickly lead the market
Financial strength and resilience
Business Model
We offer multiple investment pathways. Our licensing-out model to pharma and biotech companies generates revenue and expands market reach. In addition, our IP-driven development leverages a robust patent portfolio to create innovative solutions. Long-term investors can also benefit from our IPO and acquisition strategies. Join us on a promising investment journey. Join us for a promising investment journey.
Long-term: IPO or acquisition
Plan for long-term growth through an IPO or acquisition by a major company, unlocking significant value and maximizing investor returns.
Licensing-out model to pharma/biotech
Establish strategic partnerships with pharma and biotech companies through licensing-out, creating mutual benefits and maximizing the value of our technologies.
Connect with Arviva Therapeutics
Contact Us